Hui-Jun Cao
Overview
Explore the profile of Hui-Jun Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia J, Ma N, Shi Q, Liu Q, Zhang W, Cao H, et al.
J Cell Biol
. 2023 Dec;
223(2).
PMID: 38095639
Metastasis is the main cause of colorectal cancer (CRC)-related death, and the 5-year relative survival rate for CRC patients with distant metastasis is only 14%. X-linked inhibitor of apoptosis (XIAP)-associated...
2.
Zheng Q, Ni Q, Zhu B, Liang X, Ma N, Wang Y, et al.
Oncogene
. 2023 Jul;
42(35):2655-2656.
PMID: 37491607
No abstract available.
3.
Wang Y, Ma N, Xu S, Huang J, Ni Q, Cao H, et al.
Cell Rep
. 2023 Apr;
42(4):112340.
PMID: 37027301
Pancreatic progenitor cell differentiation and proliferation factor (PPDPF) has been reported to play a role in tumorigenesis. However, its function in hepatocellular carcinoma (HCC) remains poorly understood. In this study,...
4.
Ni Q, Zhu B, Ji Y, Zheng Q, Liang X, Ma N, et al.
Adv Sci (Weinh)
. 2022 Dec;
10(2):e2202448.
PMID: 36453576
The guanine nucleotide exchange factor (GEF) SOS1 catalyzes the exchange of GDP for GTP on RAS. However, regulation of the GEF activity remains elusive. Here, the authors report that PPDPF...
5.
Cao H, Jiang H, Ding K, Qiu X, Ma N, Zhang F, et al.
Cell Death Differ
. 2022 Nov;
30(2):383-396.
PMID: 36396719
Non-alcoholic fatty liver disease (NAFLD) has become a growing public health problem. However, the complicated pathogenesis of NAFLD contributes to the deficiency of effective clinical treatment. Here, we demonstrated that...
6.
Zheng Q, Ni Q, Zhu B, Liang X, Ma N, Wang Y, et al.
Oncogene
. 2022 Jul;
41(36):4244-4256.
PMID: 35906391
Lung cancer is the most common malignancy and the leading cause of cancer death worldwide, and lung adenocarcinoma (LUAD) is the most prevalent subtype. Considering the emergence of resistance to...
7.
Zhang F, Ni Q, Wang K, Cao H, Guan D, Zhang E, et al.
Cell Mol Gastroenterol Hepatol
. 2022 Apr;
14(1):101-127.
PMID: 35390516
Background & Aims: Hepatocellular carcinoma (HCC) is a highly heterogeneous solid tumor with high morbidity and mortality. AT-rich interaction domain 1A (ARID1A) accounts for up to 10% of mutations in...
8.
Zheng Q, Ding X, Cao H, Ni Q, Zhu B, Ma N, et al.
Toxins (Basel)
. 2021 Nov;
13(11).
PMID: 34822586
Ochratoxin A(OTA) is considered to be one of the most important contaminants of food and feed worldwide. The liver is one of key target organs for OTA to exert its...
9.
Zhang E, Zhang X, Wang K, Zhang F, Chen T, Ma N, et al.
Oncogene
. 2021 Jul;
40(34):5302-5313.
PMID: 34247189
The prognosis of hepatocellular carcinoma (HCC) remains unsatisfactory due to limited effective treatment options. In this work, we investigated the therapeutic efficacy of Terbinafine for HCC and the underlying mechanism....
10.
Ma N, Wang Y, Xu S, Ni Q, Zheng Q, Zhu B, et al.
Nat Commun
. 2021 May;
12(1):3059.
PMID: 34031390
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease in the world, however, no drug treatment has been approved for this disease. Thus, it is urgent...